ExoFlex

Propulsé - Medical Device | Été 2025

About the company

The objective of ExoFlex is to develop a range of products aimed at increasing the autonomy of individuals with neuromuscular diseases. Our first device on the market will be a motorized station to assist with calf and hamstring stretching, providing patients with greater independence and well-being. Our technology simplifies stretching, allows for increased frequency, and reduces the workload for caregivers.

The founders

Olivier Jackson
Président
Félix Roy
CEO
Simon Chayer
Secrétaire

Exclaro-Tridan

Hiver 2023
About the company
We aim to deliver quick screening tests by offering a user-friendly point-of-care solution for multiple results rapidly using body fluids (saliva, urine and blood). We are currently focused on drug screening and athlete health.
The founders

François Daoust

Nassim Ksantini

Technologies Aquilix

Été 2026
About the company
Aquilix leverages video streams from construction sites to provide real-time visibility into operations. The platform automatically analyzes footage to detect safety (OHS) violations, track work progress, and monitor overall site activity. By turning existing cameras into analytical tools, Aquilix helps reduce risks, improve productivity, and generate clear automated reports for...
The founders

Jules Gaudet

Simon Roy

Samuel Barbeau

Valence Discovery

Été 2018
About the company
Valence unlocks the true potential of deep learning in drug design by unifying best-in-class deep learning technologies with an intuitive infrastructure to enable any drug discovery team to become AI-enabled. Valence (formerly InVivo AI) is proudly based at Mila, the largest deep learning research institute in the world.
The founders

Therence Bois

Daniel Cohen

Prudencio Tossou

Sébastien Giguère

Subscribe to newsletter

Name
Subscribe to the newsletter(Required)